gadolinium dtpa has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, JC; Gan, Y; Liu, Q; Liu, Y; Shi, FD; Turner, GH | 1 |
| Furiya, Y; Kataoka, H; Kawahara, M; Kichikawa, K; Kiriyama, T; Morikawa, M; Sugie, K; Tanizawa, E; Taoka, T; Terashima, M; Tonomura, Y; Ueno, S | 1 |
| Chatterjee, S; Kesavadas, C; Saini, J; Thomas, B | 1 |
| Gärtner, S; Heckl, S; Herrmann, M; Klose, U; Küker, W; Nägele, T; Schick, F; Weissert, R | 1 |
| Cho, BM; Kim, HJ; Kim, YW; Lee, TH; Moon, TY; Park, BR; Pyeun, YS; Suh, KT | 1 |
| Jacobs, PM; Manninger, SP; Muldoon, LL; Murillo, T; Nesbit, G; Neuwelt, EA | 1 |
| Ito, K; Kobayashi, S; Kurihara, K; Nakamura, I; Tanno, M | 1 |
| Bertorini, T; Halford, H; Lawrence, J; Vo, D; Wassef, M | 1 |
| Niino, M; Tashiro, K; Tsuji, S | 1 |
| Barkhof, F; Tan, IL; van der Meijs, AH | 1 |
| Bidgood, WD; Guy, J; Mancuso, A; Mao, J; Quisling, RG | 1 |
| Ellis, EA; Fitzsimmons, J; Guy, J; Mancuso, A | 1 |
12 other study(ies) available for gadolinium dtpa and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
Visualization of inflammation and demyelination in 2D2 transgenic mice with rodent MRI.
Topics: Analysis of Variance; Animals; Aquaporin 4; Blood-Brain Barrier; Demyelinating Diseases; Disease Progression; Female; Gadolinium DTPA; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Inflammation; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Optic Nerve; Receptors, Antigen, T-Cell, alpha-beta; Spinal Cord; Time Factors | 2013 |
Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
Topics: Adolescent; Adult; Brain Chemistry; Brain Diseases; Contrast Media; Demyelinating Diseases; Diagnosis, Differential; Disability Evaluation; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis | 2011 |
Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Brain Mapping; Child; Choline; Contrast Media; Demyelinating Diseases; Diffusion Magnetic Resonance Imaging; Female; Follow-Up Studies; Gadolinium DTPA; Glutamic Acid; Glutamine; Humans; Image Enhancement; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Young Adult | 2011 |
Experimental autoimmune encephalomyelitis (EAE): lesion visualization on a 3 Tesla clinical whole-body system after intraperitoneal contrast injection.
Topics: Adrenergic alpha-Agonists; Anesthetics, Dissociative; Animals; Brain; Brain Stem; Cerebellum; Contrast Media; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Gadolinium DTPA; Injections, Intraperitoneal; Ketamine; Magnetic Resonance Imaging; Rats; Spinal Cord; Xylazine | 2004 |
A model for research on the blood-brain barrier disruption induced by unsaturated fatty acid emulsion.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Carotid Artery, Internal; Cats; Demyelinating Diseases; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Emulsions; Gadolinium DTPA; Image Enhancement; Injections, Intra-Arterial; Linoleic Acid; Necrosis; Oleic Acid; Time Factors | 2005 |
An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions.
Topics: Adolescent; Adult; Aged; Blood-Brain Barrier; Brain; Brain Neoplasms; Central Nervous System Diseases; Cerebrovascular Disorders; Contrast Media; Demyelinating Diseases; Dextrans; Female; Ferrosoferric Oxide; Gadolinium DTPA; Humans; Inflammation; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Nanostructures; Oxides; Phagocytes | 2005 |
New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Central Nervous System Diseases; Contrast Media; Demyelinating Diseases; Female; Gadolinium DTPA; Humans; Infliximab; Magnetic Resonance Imaging; Male; Middle Aged; Steroids; Tumor Necrosis Factor-alpha | 2006 |
Contrast-enhanced magnetic resonance imaging of the lumbosacral roots in the dysimmune inflammatory polyneuropathies.
Topics: Adult; Aged; Biopsy; Charcot-Marie-Tooth Disease; Chronic Disease; Contrast Media; Demyelinating Diseases; Electromyography; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Neural Conduction; Organometallic Compounds; Pentetic Acid; Polyradiculoneuropathy; Polyradiculopathy; Spinal Nerve Roots | 1995 |
Chronic inflammatory demyelinating polyneuropathy with multiple hypertrophic nerves in intracranial, and intra- and extra-spinal segments.
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Cranial Nerves; Demyelinating Diseases; Gadolinium DTPA; Humans; Hypertrophy; Magnetic Resonance Imaging; Male; Peripheral Nervous System Diseases; Prednisolone; Spinal Nerve Roots | 1999 |
Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis.
Topics: Adolescent; Adult; Clinical Trials, Phase III as Topic; Demyelinating Diseases; Female; Gadolinium DTPA; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Trigeminal Nerve; Trigeminal Nerve Diseases | 2002 |
Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging.
Topics: Adult; Contrast Media; Demyelinating Diseases; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Optic Nerve Diseases; Optic Neuritis; Orbit; Organometallic Compounds; Pentetic Acid; Visual Acuity | 1992 |
Gadolinium-DTPA-enhanced magnetic resonance imaging in experimental optic neuritis.
Topics: Animals; Demyelinating Diseases; Disease Models, Animal; Gadolinium DTPA; Guinea Pigs; Image Enhancement; Magnetic Resonance Imaging; Optic Chiasm; Optic Nerve; Optic Neuritis; Organometallic Compounds; Pentetic Acid; Permeability | 1990 |